Cytokinetics, Incorporated

Articles by Cytokinetics, Incorporated

Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy - Cytokinetics

Business May 6, 2026

Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise PerformanceΒ With Consistent Positive Findings Across Key Secondary Endpoints Company to Host Conference Call and Webcast Tuesday May 5 a...